Related Experiment Video
Updated: Aug 20, 2025
07:59
Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
Published on: April 25, 2025
455
Community-acquired Acinetobacter baumannii pneumonia: a rare case in Brazil
Izadora Raduan Brigo1, Leandro de Resende Yamamoto1, Rodrigo Juliano Molina1
1Universidade Federal do Triângulo Mineiro, Departamento de Clínica Médica, Uberaba, MG, Brasil.
Revista Da Sociedade Brasileira De Medicina Tropical
|November 23, 2022
Summary
Acinetobacter baumannii causes rare community-acquired pneumonia, posing diagnostic and treatment challenges due to its multidrug resistance and rapid progression. This study found no similar cases in Brazil, highlighting a gap in understanding this pathogen outside hospital settings.
Area of Science:
- Infectious Diseases
- Microbiology
- Clinical Medicine
Background:
- Acinetobacter baumannii is a significant cause of hospital-acquired infections.
- Community-acquired pneumonia (CAP) is rarely attributed to Acinetobacter baumannii.
Observation:
- This report details a case of Acinetobacter baumannii pneumonia acquired outside a hospital setting.
- The microorganism exhibits multidrug resistance, complicating treatment strategies.
- Clinical progression was rapid and unfavorable, underscoring the severity of the infection.
Findings:
- Early diagnosis of community-acquired Acinetobacter baumannii pneumonia is challenging.
- Effective treatment options are limited due to antimicrobial resistance.
- A comprehensive literature search revealed no previously reported community-acquired cases in Brazil.
Implications:
- This case highlights the potential for Acinetobacter baumannii to cause severe community-acquired infections.
- Increased vigilance and diagnostic capabilities are needed for non-nosocomial Acinetobacter baumannii infections.
- Further research is warranted to understand the epidemiology and clinical outcomes of community-acquired Acinetobacter baumannii globally, particularly in regions like Brazil.
Related Concept Videos
01:30Pneumonia I: Introduction
301
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
301
01:26Pulmonary Tuberculosis IV
186
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
186
01:30Pneumonia III: Complications and Assessment
353
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
353
01:28Pneumonia IV: Management
424
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
424
01:29Acute Respiratory Failure-V
182
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
182
01:21Acute Respiratory Failure-I
283
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
283